{
    "2021-04-15": [
        [
            {
                "time": "",
                "original_text": "306家药企晒2020成绩单！超40家亏损，77家翻倍，云南白药、复星……狂赚超30亿亏损",
                "features": {
                    "keywords": [
                        "药企",
                        "2020成绩单",
                        "亏损",
                        "翻倍",
                        "云南白药",
                        "复星"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "西南证券：云南白药（000538.SZ）国企混改落地，维持“买入”评级",
                "features": {
                    "keywords": [
                        "西南证券",
                        "云南白药",
                        "国企混改",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券--云南白药:国企混改落地，新白药快速启航【公司研究】",
                "features": {
                    "keywords": [
                        "西南证券",
                        "云南白药",
                        "国企混改",
                        "新白药",
                        "启航"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}